Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694198,Abfw3,Abdominal fat weight QTL 3,16.13,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),5,116767924,161767924,Rat,n/a,region,qtl 1000,1641912,Alcrsp18,Alcohol response QTL 18,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),5,35788756,147487820,Rat,n/a,region,qtl 1000,2306971,Anxrr21,Anxiety related response QTL 21,9.47,,fear/anxiety-related behavior trait (VT:1000241),number of entries into a discrete space in an experimental apparatus (CMO:0000960),5,65696672,129038896,Rat,n/a,region,qtl 1000,634350,Apr4,Acute phase response QTL 4,6,,orosomucoid 1 amount (VT:0010541),plasma orosomucoid 1 level (CMO:0001467),12,4210051,49210051,Rat,n/a,region,qtl 1000,634351,Apr5,Acute phase response QTL 5,6.7,,blood interleukin-6 amount (VT:0008595),plasma interleukin-6 level (CMO:0001927),12,2513442,47513442,Rat,n/a,region,qtl 1000,1578673,Bmd13,Bone mineral density QTL 13,4.9,,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),5,107119214,152119214,Rat,n/a,region,qtl 1000,1298086,Bp156,Blood pressure QTL 156,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,89502294,134502294,Rat,n/a,region,qtl 1000,1331761,Bp218,Blood pressure QTL 218,2.973,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),12,13127211,50320041,Rat,n/a,region,qtl 1000,1331755,Bp219,Blood pressure QTL 219,3.041,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),12,13127211,31723688,Rat,n/a,region,qtl 1000,1358895,Bp254,Blood pressure QTL 254,3.6,0.0003,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,60072951,133313852,Rat,n/a,region,qtl 1000,1358889,Bp261,Blood pressure QTL 261,2.86,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,93037304,133313852,Rat,n/a,region,qtl 1000,1598846,Bp293,Blood pressure QTL 293,3.9,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,83424556,128424556,Rat,n/a,region,qtl 1000,1598855,Bp294,Blood pressure QTL 294,3.5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),12,1,36919844,Rat,n/a,region,qtl 1000,61393,Bp7,Blood pressure QTL 7,4.5,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,61612600,168109659,Rat,n/a,region,qtl 1000,7207481,Bss106,Bone structure and strength QTL 106,7.9,,femur strength trait (VT:0010010),femur ultimate force (CMO:0001675),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207486,Bss109,Bone structure and strength QTL 109,,,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207488,Bss110,Bone structure and strength QTL 1,8.4,,femur strength trait (VT:0010010),femur stiffness (CMO:0001674),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207491,Bss112,Bone structure and strength QTL 112,7,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),5,112279412,157279412,Rat,n/a,region,qtl 1000,1549838,Bss4,Bone structure and strength QTL 4,9.2,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),5,112279412,157279412,Rat,n/a,region,qtl 1000,6893681,Bw109,Body weight QTL 109,2.3,0.004,body mass (VT:0001259),body weight (CMO:0000012),12,1,23758197,Rat,n/a,region,qtl 1000,6903316,Bw113,Body weight QTL 113,2,0.0103,body mass (VT:0001259),body weight (CMO:0000012),5,91884213,136884213,Rat,n/a,region,qtl 1000,7411545,Bw128,Body weight QTL 128,5.2,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,7411547,Bw129,Body weight QTL 129,,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),6,9223626,52716770,Rat,n/a,region,qtl 1000,7411564,Bw135,Body weight QTL 135,,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,91585539,136585539,Rat,n/a,region,qtl 1000,8694179,Bw150,Body weight QTL 150,2.9,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,8694389,Bw160,Body weight QTL 160,6.17,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),5,116767924,161767924,Rat,n/a,region,qtl 1000,8694441,Bw169,Body weight QTL 169,17.61,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),5,116767924,161767924,Rat,n/a,region,qtl 1000,1582230,Bw78,Body weight QTL 78,3.2,0.0016,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),5,123852489,133313852,Rat,n/a,region,qtl 1000,61452,Ciaa5,CIA Autoantibody QTL 5,3.5,,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),5,97921932,149030144,Rat,n/a,region,qtl 1000,1581516,Cm56,Cardiac mass QTL 56,4.2,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),12,1,30749723,Rat,n/a,region,qtl 1000,1598847,Cm62,Cardiac mass QTL 62,3.4,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,114140832,159140832,Rat,n/a,region,qtl 1000,1598859,Cm66,Cardiac mass QTL 66,2,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,83424556,128424556,Rat,n/a,region,qtl 1000,10755457,Coatc14,Coat color QTL 14,,0.01759,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),12,1,23035872,Rat,n/a,region,qtl 1000,61331,Eau2,Experimental allergic uveoretinitis QTL 2,,0.0005,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),12,10256890,31723732,Rat,n/a,region,qtl 1000,1600391,Edcs2,Endometrial carcinoma susceptibility QTL2,3.5,0.01,uterus morphology trait (VT:0001120),percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759),12,8249608,20590080,Rat,n/a,region,qtl 1000,1358187,Emca1,Estrogen-induced mammary cancer QTL 1,4.4,,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),5,102945579,154732228,Rat,n/a,region,qtl 1000,1576312,Emca8,Estrogen-induced mammary cancer QTL 8,4.1,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,51418671,147487820,Rat,n/a,region,qtl 1000,7411597,Foco10,Food consumption QTL 10,,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411601,Foco12,Food consumption QTL 12,19.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),5,91585539,136585539,Rat,n/a,region,qtl 1000,7411641,Foco19,Food consumption QTL 19,27.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411660,Foco28,Food consumption QTL 28,10.9,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411582,Foco3,Food consumption QTL 3,7.5,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),5,91585539,136585539,Rat,n/a,region,qtl 1000,7411586,Foco5,Food consumption QTL 5,5.4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411588,Foco6,Food consumption QTL 6,,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411595,Foco9,Food consumption QTL 9,4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,2317753,Glom24,Glomerulus QTL 24,3.1,,kidney glomerulus integrity trait (VT:0010546),kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269),5,101265591,141912026,Rat,n/a,region,qtl 1000,1331739,Hrtrt14,Heart rate QTL 14,3.56232,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),12,11764995,14489679,Rat,n/a,region,qtl 1000,2293086,Iddm30,Insulin dependent diabetes mellitus QTL 30,3.82,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),12,10175889,31975590,Rat,n/a,region,qtl 1000,9590086,Insglur6,Insulin/glucose ratio QTL 6,18.97,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),12,150810,45150810,Rat,n/a,region,qtl 1000,2303575,Insul14,Insulin level QTL 14,4,,blood insulin amount (VT:0001560),blood insulin level (CMO:0000349),12,492578,45492578,Rat,n/a,region,qtl 1000,1331786,Kidm11,Kidney mass QTL 11,3.571,,kidney mass (VT:0002707),right kidney wet weight (CMO:0000082),12,13127211,27285590,Rat,n/a,region,qtl 1000,1358909,Kidm25,Kidney mass QTL 25,1.87,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),5,93037304,133313852,Rat,n/a,region,qtl 1000,2312418,Kidm41,Kidney mass QTL 41,3.7,0.0001,kidney mass (VT:0002707),single kidney wet weight to body weight ratio (CMO:0000622),12,1,22650917,Rat,n/a,region,qtl 1000,7387292,Kidm42,Kidney mass QTL 42,3.03,0.0004,kidney mass (VT:0002707),left kidney wet weight (CMO:0000083),12,1,38334225,Rat,n/a,region,qtl 1000,10059594,Kidm46,Kidney mass QTL 46,3.79,0.025,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),12,9789834,52716770,Rat,n/a,region,qtl 1000,70189,Mcs5,Mammary carcinoma susceptibility QTL 5,10.51,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,56991667,137729065,Rat,n/a,region,qtl 1000,70212,Niddm25,Non-insulin dependent diabetes mellitus QTL 25,3.54,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,1,136640934,Rat,n/a,region,qtl 1000,737979,Pia22,Pristane induced arthritis QTL 22,53.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),12,2475687,47475687,Rat,n/a,region,qtl 1000,2302042,Pia38,Pristane induced arthritis QTL 38,3.5,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),12,2513442,47513442,Rat,n/a,region,qtl 1000,8552960,Pigfal15,Plasma insulin-like growth factor 1 level QTL 15,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),5,116767924,161767924,Rat,n/a,region,qtl 1000,8552964,Pigfal17,Plasma insulin-like growth factor 1 level QTL 17,3.5,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223626,52716770,Rat,n/a,region,qtl 1000,8552912,Pigfal6,Plasma insulin-like growth factor 1 level QTL 6,5,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223630,52716770,Rat,n/a,region,qtl 1000,8552918,Pigfal7,Plasma insulin-like growth factor 1 level QTL 7,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223626,52716770,Rat,n/a,region,qtl 1000,1300157,Rf21,Renal function QTL 21,4.4,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),12,11764995,37522089,Rat,n/a,region,qtl 1000,1331801,Rf33,Renal function QTL 33,4.149,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),5,44404276,134502294,Rat,n/a,region,qtl 1000,1298089,Scl14,Serum cholesterol level QTL 14,5.8,0.0004,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,114140832,159140832,Rat,n/a,region,qtl 1000,1298070,Scl18,Serum cholesterol level QTL 18,3.7,,blood LDL cholesterol amount (VT:0000181),calculated plasma low density lipoprotein cholesterol level (CMO:0001245),5,83424556,128424556,Rat,n/a,region,qtl 1000,61426,Scl2,Serum cholesterol level QTL 2,7.3,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,61086525,149030144,Rat,n/a,region,qtl 1000,1302790,Scl20,Serum cholesterol level QTL 20,6.4,0.0001,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,84963058,173504662,Rat,n/a,region,qtl 1000,1302792,Scl21,Serum cholesterol level QTL 21,3.8,0.0011,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),12,8954593,27911196,Rat,n/a,region,qtl 1000,1549845,Scl44,Serum cholesterol level QTL 44,6,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,40777918,154732375,Rat,n/a,region,qtl 1000,2290448,Scl54,Serum cholesterol level QTL 54,2.93,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,31926122,136640934,Rat,n/a,region,qtl 1000,9590147,Scort7,Serum corticosterone level QTL 7,13.61,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),12,150810,45150810,Rat,n/a,region,qtl 1000,1354598,Srn6,Serum renin concentration QTL 6,3.8,,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),5,71552569,157225114,Rat,n/a,region,qtl 1000,10450854,Stl34,Serum triglyceride level QTL 34,3.5,0.05,blood LDL triglyceride amount (VT:0010699),blood lipoprotein triglyceride level (CMO:0002685),12,1,22853017,Rat,n/a,region,qtl 1000,1578766,Tcas11,Tongue tumor susceptibility QTL 11,4.12,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),5,47745646,167946134,Rat,n/a,region,qtl 1000,1331796,Thshl2,Thyroid stimulating hormone level QTL 2,2.3,,blood thyroid-stimulating hormone amount (VT:0005119),serum thyroid stimulating hormone level (CMO:0001248),5,100723739,153577831,Rat,n/a,region,qtl 1000,631527,Tls1,T-lymphoma susceptibility QTL 1,0,0.001,thymus integrity trait (VT:0010555),post-insult time to onset of T-cell lymphoma (CMO:0001907),5,93273130,138273130,Rat,n/a,region,qtl 1000,2317056,Wbc3,White blood cell count QTL 3,2.51,0.01,leukocyte quantity (VT:0000217),white blood cell count (CMO:0000027),5,111278451,156278451,Rat,n/a,region,qtl